| Mar 27, 2014
| 5:20 AM
BALTIMORE Talk about closing the barn door years after the rustlers have made off with your horses!
U.S. Food and Drug Administration Commissioner Margaret Hamburg returned last month from her first official trip to India seeking to persuade the Indian...
| Mar 15, 2014
| 6:19 PM
It costs about $2,000 to buy an ounce of the illegal drug, the therapist said — enough for roughly 150 doses. She pays her longtime dealer in cash; he gives her a Ziploc bag of white powder.
Back home, she scoops the contents into clear capsules....
| Feb 10, 2014
| 5:57 PM
Here's how Toyota Motor Corp. plans to finally put the sudden-acceleration issue to rest: Pull out the checkbook.
The automaker is reportedly close to paying a $1-billion fine to settle a four-year federal criminal investigation into whether it properly...
| Jan 23, 2014
| 6:45 AM
Residents interested in Solarize Enfield have until April 15 to sign contracts under the Solarize program.
Solarize Enfield offers discounted rates on solar systems through a state-town sponsored program, and the average Solarize customer can expect...
| Dec 26, 2013
| 12:44 PM
In his recently published "1913: The Year Before The Storm," German journalist Florian Illies compiles a fascinating and exhaustively researched month-by-month compendium of the events, personalities, culture, politics, technology and fashions that shaped...
| Dec 18, 2013
| 11:55 AM
Followers of Herbalife, the Los Angeles peddler of nutritional supplements, know it's actually two stories rolled into one.
One is the story of how a company with a questionable business model, overhyped products, and an almost invisible research and...
| Nov 21, 2013
Pneumonia, flu and shingles all affect seniors disproportionately to the rest of the population. These vaccine-preventable diseases account for more than 50,000 deaths annually in the U.S., according to the Alliance for Aging Research in its newly...
| Nov 14, 2013
| 4:38 PM
Members of an experimental class of cholesterol-lowering drugs could get U.S. regulatory approval based on their ability to lower "bad" cholesterol, and may not need to show that they reduce the risk of heart attack and stroke, the Food and Drug...
| Nov 6, 2013
| 6:46 AM
WASHINGTON -- Planned layoffs by U.S. employers jumped 13.5% last month, led by cutbacks at pharmaceutical and financial services firms, according to a report Wednesday.
Employers announced plans to cut 45,730 jobs in October, up from 40,289 the...
| Oct 1, 2013
| 8:33 AM
Merck & Co., the second-largest drug maker by sales, said Tuesday it will lay off 8,500 employees in a strategy overhaul to revamp its research and development efforts.
That's on top of a previous announcement that the Whitehouse Station, N.J.-based...
| Sep 16, 2013
| 5:33 PM
The Food & Drug Administration on Monday barred the import of any medications made at the premier manufacturing plant of one of the world's largest makers of generic medications, Ranbaxy Laboratories Ltd.
The FDA cited Ranbaxy's failure to respond...